This site is intended for healthcare professionals only
LoginRegister

Pulmonology Dialogues

Bayer begins Phase IIa trial of BAY 3401016 for Alport Syndrome

Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer

Berlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...
View All

Latest News and Guidelines

Early-Onset COPD in Young Adults Linked to Higher Mortality and Morbidity: Study

Early-Onset COPD in Young Adults Linked to Higher Mortality and Morbidity: Study

COVID

Pneumococcal Vaccine Linked to Better COVID-19 Outcomes in IRD Patients: Study

No Major Advantage Seen With mPCR and Procalcitonin Combo in ICU-Treated Pneumonia: MULTI-CAP Trial

No Major Advantage Seen With mPCR and Procalcitonin Combo in ICU-Treated Pneumonia: MULTI-CAP Trial

Roche gets negative EMA Committee opinion on Elevidys CMA

Roche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular...

AD109 shows positive results for Obstructive sleep apnea in Phase 3 Results

AD109 shows positive results for Obstructive sleep apnea in Phase 3 Results

Tezepelumab effective as Add-On Therapy in Both T2-High and T2-Low Severe Asthma: Study

Tezepelumab effective as Add-On Therapy in Both T2-High and T2-Low Severe Asthma: Study

View All
X